528 related articles for article (PubMed ID: 20664282)
21. An evidence based therapeutic approach to hereditary and acquired angioedema.
Bork K
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
[TBL] [Abstract][Full Text] [Related]
22. Successful management with C1-inhibitor concentrate of hereditary angioedema attacks during two successive pregnancies: a case report.
Hermans C
Arch Gynecol Obstet; 2007 Sep; 276(3):271-6. PubMed ID: 17653743
[TBL] [Abstract][Full Text] [Related]
23. The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey.
Czaller I; Visy B; Csuka D; Füst G; Tóth F; Farkas H
Eur J Obstet Gynecol Reprod Biol; 2010 Sep; 152(1):44-9. PubMed ID: 20541309
[TBL] [Abstract][Full Text] [Related]
24. Hereditary angioedema: new hopes for an orphan disease.
Reshef A; Leibovich I; Goren A
Isr Med Assoc J; 2008 Dec; 10(12):850-5. PubMed ID: 19160940
[TBL] [Abstract][Full Text] [Related]
25. Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate.
Zuraw BL; Cicardi M; Longhurst HJ; Bernstein JA; Li HH; Magerl M; Martinez-Saguer I; Rehman SM; Staubach P; Feuersenger H; Parasrampuria R; Sidhu J; Edelman J; Craig T
Allergy; 2015 Oct; 70(10):1319-28. PubMed ID: 26016741
[TBL] [Abstract][Full Text] [Related]
26. [Hereditary angioedema--treatment].
Muszyńska A; Fal AM
Pol Merkur Lekarski; 2008 Jul; 25(145):94-6. PubMed ID: 18839625
[TBL] [Abstract][Full Text] [Related]
27. Long-term prophylaxis of hereditary angioedema with androgen derivates: a critical appraisal and potential alternatives.
Maurer M; Magerl M
J Dtsch Dermatol Ges; 2011 Feb; 9(2):99-107. PubMed ID: 20946572
[TBL] [Abstract][Full Text] [Related]
28. Hereditary angioedema: an update on available therapeutic options.
Maurer M; Magerl M
J Dtsch Dermatol Ges; 2010 Sep; 8(9):663-72. PubMed ID: 20602665
[TBL] [Abstract][Full Text] [Related]
29. Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema.
Bork K; Staubach P; Hardt J
Allergy; 2008 Jun; 63(6):751-7. PubMed ID: 18445189
[TBL] [Abstract][Full Text] [Related]
30. Modeling Cost-Effectiveness of On-Demand Treatment for Hereditary Angioedema Attacks.
Bernstein JA; Tyson C; Relan A; Adams P; Magar R
J Manag Care Spec Pharm; 2020 Feb; 26(2):203-210. PubMed ID: 31841366
[TBL] [Abstract][Full Text] [Related]
31. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and treatment of hereditary angioedema.
Canonica GW; Rossi O
Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
[TBL] [Abstract][Full Text] [Related]
34. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
[TBL] [Abstract][Full Text] [Related]
35. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
Sabharwal G; Craig T
Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
[TBL] [Abstract][Full Text] [Related]
36. [EFFICACY, PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF INTRAVENOUS C1 INHIBITOR FOR LONG-TERM PROPHYLAXIS AND TREATMENT OF BREAKTHROUGH ATTACKS IN JAPANESE SUBJECTS WITH HEREDITARY ANGIOEDEMA: A PHASE 3 OPEN-LABEL STUDY].
Fukunaga A; Morita E; Miyagi T; Eto K; Shimizu A; Kagami S; Yamamoto H; Vardi M; Tang Y; Wang Y; Hide M
Arerugi; 2020; 69(3):192-203. PubMed ID: 32435020
[TBL] [Abstract][Full Text] [Related]
37. C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies.
Schneider L; Hurewitz D; Wasserman R; Obtulowicz K; Machnig T; Moldovan D; Reshef A; Craig TJ
Pediatr Allergy Immunol; 2013 Feb; 24(1):54-60. PubMed ID: 23173714
[TBL] [Abstract][Full Text] [Related]
38. Molecular diagnosis and management of hereditary angioedema in a Greek family.
Papadopoulou-Alataki E; Foerster T; Antari V; Pavlitou-Tsiontsi A; Varlamis G
Int Arch Allergy Immunol; 2008; 147(2):166-70. PubMed ID: 18535392
[TBL] [Abstract][Full Text] [Related]
39. Parameters of the classical complement pathway predict disease severity in hereditary angioedema.
Csuka D; Füst G; Farkas H; Varga L
Clin Immunol; 2011 Apr; 139(1):85-93. PubMed ID: 21300570
[TBL] [Abstract][Full Text] [Related]
40. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.
Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Relan A; Visscher S; Haase G; Kaufman L; Hack CE
J Allergy Clin Immunol; 2010 Oct; 126(4):821-827.e14. PubMed ID: 20920772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
